ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Harnessing The Power Of eCOA Technology

  Get an overview of this COA-focused panel at the C3 Summit in London where industry experts and leaders discussed challenges, opportunities, and strategies in clinical trial diversity, centricity, and outcome assessments.

• To Counter Bias, Counterbalance

  It’s easy to overlook the effects a survey’s format can have on responses, but those effects are potent sources of bias. Modern EDC allows you to systematically vary both question and response option order. This practice, called counterbalancing, guards against unwanted order effects.

• Fulfilling MDR Requirements For A Groundbreaking Microsurgery Robot

  Discover the help a company pioneering the field of open surgery received to advance their robotic technology, replacing their former EDC system to improve their clinical research efficiency.

• 3 Proven eConsent Implementation And Adoption Best Practices

  By advocating these three essential best practices, learn how stakeholders can navigate the complexities of eConsent adoption with confidence and enhance the overall efficiency and success of clinical trials.

• Data Quality And How It Impacts Clinical Trials

  Explore a shared platform that helps organizations overcome technical burdens, reduce expenditures, and accelerate the delivery of innovative therapies.

• Accelerating Study Startups: Drive Efficiency From Protocol To Go-Live

  Speed up trial launches and maintain predictable timelines by leveraging a modern, integrated approach to eCOA setup that reduces complexity.

• Developing Drugs For Rare Diseases: Generating Clinical Evidence

  For rare diseases, scientific breakthroughs often stall before reaching patients. A new approach to generating clinical evidence could change that trajectory.

• The Final DCT Guidance: I'm Not Mad At It

  Explore the FDA's 2024 final guidance on DCTs, including key updates that address previous concerns, affecting healthcare providers, sub-investigators, and sponsors.

• How Vanguard Clinical Harnesses CDMS/EDC For Faster Results

  Uncover how this CRO was able to stay agile by choosing a CDMS/EDC partner that prioritized sponsor needs and streamlined operations to achieve top-tier results swiftly.

• Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial

  Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.